Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Cataldo Patruno and Gabriella Fabbrocini.
Connection Strength

4.589
  1. Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis. 2021 09; 9(3):622-623.
    View in: PubMed
    Score: 0.952
  2. Treatment of Atopic Dermatitis with Biologic Drugs. Dermatol Ther (Heidelb). 2018 Dec; 8(4):527-538.
    View in: PubMed
    Score: 0.784
  3. Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111.
    View in: PubMed
    Score: 0.241
  4. Safety of dupilumab in atopic patients during COVID-19 outbreak. J Dermatolog Treat. 2022 Feb; 33(1):600-601.
    View in: PubMed
    Score: 0.222
  5. Biologics for psoriasis in COVID-19 era: What do we know? Dermatol Ther. 2020 07; 33(4):e13467.
    View in: PubMed
    Score: 0.222
  6. Is climate change the next pandemic for dermatology? Lessons from COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13682.
    View in: PubMed
    Score: 0.222
  7. The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis. 2020 08; 83(2):174-175.
    View in: PubMed
    Score: 0.221
  8. Dupilumab and COVID-19: What should we expect? Dermatol Ther. 2020 Jul; 33(4):e13502.
    View in: PubMed
    Score: 0.221
  9. COVID-19, quarantine, and atopic dermatitis. Med Hypotheses. 2020 10; 143:109852.
    View in: PubMed
    Score: 0.221
  10. Reply: Potential role of Janus kinase inhibitors in COVID-19. J Am Acad Dermatol. 2020 07; 83(1):e65.
    View in: PubMed
    Score: 0.220
  11. Allergic contact dermatitis in patients with atopic dermatitis: A retrospective study. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2459-2461.
    View in: PubMed
    Score: 0.204
  12. Adult atopic dermatitis: new and emerging therapies. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):867-878.
    View in: PubMed
    Score: 0.195
  13. Postinflammatory hypopigmentation due to ferrous sulphate. G Ital Dermatol Venereol. 2020 Apr; 155(2):243-244.
    View in: PubMed
    Score: 0.194
  14. Contact Urticaria to Ultrasound Gel: A Case Report. Dermatitis. 2018 Mar/Apr; 29(2):93.
    View in: PubMed
    Score: 0.189
  15. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
    View in: PubMed
    Score: 0.060
  16. Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
    View in: PubMed
    Score: 0.060
  17. Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117.
    View in: PubMed
    Score: 0.059
  18. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
    View in: PubMed
    Score: 0.058
  19. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017; 10:105-115.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.